SlideShare a Scribd company logo
FDA MAUDE Data Insights
Trevor Schmaeling
MAUDE DataBase Introduction
“MAUDE data represents reports of adverse events involving
medical devices. The download data files consist of voluntary
reports since June 1993, user facility reports since 1991,
distributor reports since 1993, and manufacturer reports since
August 1996. The searchable database data contains the last 10
year's data. MAUDE may not include reports made according to
exemptions, variances, or alternative reporting requirements
granted under 21 CFR 803.19.”(FDA)
Project Background
• Project started since I wanted to be able to find my own custom
statistics on the MAUDE DB. A lot of statistics are difficult to come by,
especially on a DB that receives little attention from the general
public.
• Information I provide is based on September 2021.
• First step was to use the https://open.fda.gov/ API. However, at the
time I used it, the data provided was not up to date (most recent
month).
• The next step I took was to download the data directly from the FDA.
Collection of Data (1/2)
Collection of Data (2/2)
Check Data Structure, Then Add to DB
Example of what a Table Looks Like
151K+ rows just for 1 month
This is the Same Table Zoomed Out
Search Through Text for “cobalt”
To access the
DB I created a
basic search
interface.
Advanced Search is also an Option
More fields such
as “Date” can
also be added
Some Provided Results for “cobalt”
Cobalt Device Problems
Each “Device Code” corresponds to an actual name in text. I could have done a UNION sql search however the time it
takes to receive results is not worth it. Will be updated by changing the code to text before displaying the graph.
Cobalt Patient Outcomes
Cobalt Event Types
Search Through Text for “allergic reaction”
Some Provided Results for “allergic reaction”
Allergic Reaction Device Problems
Allergic Reaction Patient Outcomes
Allergic Reaction Event Types
Conclusions
• Being able to search through MDR Summaries is a valuable tool for
providing specific analysis.
• Visually seeing the provided Device Problems, Patient Outcomes, and
Event Types data of a keyword in an MDR summary can assist in root
problem(s) diagnostics.
• Although the MAUDE DB data is not 100% verified, the noise can be
reduced through (eventual) further in-depth queries, as well as by
looking at the trend.
FDA Provided MAUDE Warnings
• Please note that the MAUDE web search feature is limited to adverse event reports within the past 10 years.
• MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare
event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions
about the existence, severity, or frequency of problems associated with devices.
• Confirming whether a device actually caused a specific event can be difficult based solely on information provided in a
given report. Establishing a cause-and-effect relationship is especially difficult if circumstances surrounding the event
have not been verified or if the device in question has not been directly evaluated.
• MAUDE data does not represent all known safety information for a reported medical device and should be interpreted in
the context of other available information when making device-related or treatment decisions.
• Variations in trade, product, and company names affect search results. Searches only retrieve records that contain the
search term(s) provided by the requester.
• Submission of a medical device report and the FDA's release of that information is not necessarily an admission that a
product, user facility, importer, distributor, manufacturer, or medical personnel caused or contributed to the event.
• Certain types of report information are protected from public disclosure under the Freedom of Information Act (FOIA). If
a report contains trade secret or confidential business information, that text is replaced by "(b)(4)". If a report contains
personnel or medical files information, that text is replaced by "(b)(6)". The designations "(b)(4)" and "(b)(6)" refer to the
exemptions in the FOIA. For example, "(b)(4)" may be found in place of the product's composition and "(b)(6)" may be
found in place of a patient's age.
• MAUDE is updated monthly and the search page reflects the date of the most recent update. The FDA seeks to include
all reports received prior to the update but the inclusion of some reports may be delayed.

More Related Content

What's hot

Vilazodone - Comprehensive patent search
Vilazodone  - Comprehensive patent searchVilazodone  - Comprehensive patent search
Vilazodone - Comprehensive patent search
ReportsnReports
 
Rifaximin - Comprehensive patent search
Rifaximin  - Comprehensive patent searchRifaximin  - Comprehensive patent search
Rifaximin - Comprehensive patent search
ReportsnReports
 
Treprostinil - Comprehensive patent search
Treprostinil  - Comprehensive patent searchTreprostinil  - Comprehensive patent search
Treprostinil - Comprehensive patent search
ReportsnReports
 
Colesevelam - Comprehensive patent search
Colesevelam   - Comprehensive patent searchColesevelam   - Comprehensive patent search
Colesevelam - Comprehensive patent search
ReportsnReports
 
Data integrity nishodh 01092016
Data integrity nishodh 01092016Data integrity nishodh 01092016
Data integrity nishodh 01092016
Nishodh Saxena Ph. D.
 
FDA Data Integrity: Misconceptions of 21 CFR Part 11
FDA Data Integrity: Misconceptions of 21 CFR Part 11 FDA Data Integrity: Misconceptions of 21 CFR Part 11
FDA Data Integrity: Misconceptions of 21 CFR Part 11
EduQuest, Inc.
 
Automate your literature monitoring for more effective pharmacovigilance
Automate your literature monitoring for more effective pharmacovigilanceAutomate your literature monitoring for more effective pharmacovigilance
Automate your literature monitoring for more effective pharmacovigilance
Ann-Marie Roche
 
Presentation: Data Integrity – an international regulatory perspective
Presentation: Data Integrity – an international regulatory perspectivePresentation: Data Integrity – an international regulatory perspective
Presentation: Data Integrity – an international regulatory perspective
TGA Australia
 
Vemurafenib - Comprehensive patent search
Vemurafenib   - Comprehensive patent searchVemurafenib   - Comprehensive patent search
Vemurafenib - Comprehensive patent search
ReportsnReports
 
Data Integrity; Ensuring GMP Six Systems Compliance Pharma Training
Data Integrity; Ensuring GMP Six Systems Compliance Pharma TrainingData Integrity; Ensuring GMP Six Systems Compliance Pharma Training
Data Integrity; Ensuring GMP Six Systems Compliance Pharma Training
Marcep Inc.
 
FDA Data Integrity Issues - DMS hot fixes
FDA Data Integrity Issues - DMS hot fixesFDA Data Integrity Issues - DMS hot fixes
FDA Data Integrity Issues - DMS hot fixes
Vidyasagar P
 
Pharmaceutical Data integrity training
Pharmaceutical Data integrity trainingPharmaceutical Data integrity training
Pharmaceutical Data integrity training
Moataz El Halawany
 
Delta GMP Data Integrity Sept2016
Delta GMP Data Integrity Sept2016Delta GMP Data Integrity Sept2016
Delta GMP Data Integrity Sept2016
Voldemars Raimond Karklins
 
CTI Landing Page
CTI Landing PageCTI Landing Page
CTI Landing Page
Michael Passanante
 
Ensuring data integrity in pharmaceutical environment
Ensuring data integrity in pharmaceutical environmentEnsuring data integrity in pharmaceutical environment
Ensuring data integrity in pharmaceutical environment
deepak mishra
 
Types of pharmacovigilance softwares
Types of pharmacovigilance softwaresTypes of pharmacovigilance softwares
Types of pharmacovigilance softwares
Sollers College
 
Reconciliation and Literature Review and Signal Detection_Katalyst HLS
Reconciliation and Literature Review and Signal Detection_Katalyst HLSReconciliation and Literature Review and Signal Detection_Katalyst HLS
Reconciliation and Literature Review and Signal Detection_Katalyst HLS
Katalyst HLS
 
Finding the right medical device information in embase 11 2016
Finding the right medical device information in embase 11 2016Finding the right medical device information in embase 11 2016
Finding the right medical device information in embase 11 2016
Ann-Marie Roche
 
Data integrity
Data integrityData integrity
Data integrity
Kiran Kota
 
Data integrity: TGA expectations
Data integrity: TGA expectationsData integrity: TGA expectations
Data integrity: TGA expectations
TGA Australia
 

What's hot (20)

Vilazodone - Comprehensive patent search
Vilazodone  - Comprehensive patent searchVilazodone  - Comprehensive patent search
Vilazodone - Comprehensive patent search
 
Rifaximin - Comprehensive patent search
Rifaximin  - Comprehensive patent searchRifaximin  - Comprehensive patent search
Rifaximin - Comprehensive patent search
 
Treprostinil - Comprehensive patent search
Treprostinil  - Comprehensive patent searchTreprostinil  - Comprehensive patent search
Treprostinil - Comprehensive patent search
 
Colesevelam - Comprehensive patent search
Colesevelam   - Comprehensive patent searchColesevelam   - Comprehensive patent search
Colesevelam - Comprehensive patent search
 
Data integrity nishodh 01092016
Data integrity nishodh 01092016Data integrity nishodh 01092016
Data integrity nishodh 01092016
 
FDA Data Integrity: Misconceptions of 21 CFR Part 11
FDA Data Integrity: Misconceptions of 21 CFR Part 11 FDA Data Integrity: Misconceptions of 21 CFR Part 11
FDA Data Integrity: Misconceptions of 21 CFR Part 11
 
Automate your literature monitoring for more effective pharmacovigilance
Automate your literature monitoring for more effective pharmacovigilanceAutomate your literature monitoring for more effective pharmacovigilance
Automate your literature monitoring for more effective pharmacovigilance
 
Presentation: Data Integrity – an international regulatory perspective
Presentation: Data Integrity – an international regulatory perspectivePresentation: Data Integrity – an international regulatory perspective
Presentation: Data Integrity – an international regulatory perspective
 
Vemurafenib - Comprehensive patent search
Vemurafenib   - Comprehensive patent searchVemurafenib   - Comprehensive patent search
Vemurafenib - Comprehensive patent search
 
Data Integrity; Ensuring GMP Six Systems Compliance Pharma Training
Data Integrity; Ensuring GMP Six Systems Compliance Pharma TrainingData Integrity; Ensuring GMP Six Systems Compliance Pharma Training
Data Integrity; Ensuring GMP Six Systems Compliance Pharma Training
 
FDA Data Integrity Issues - DMS hot fixes
FDA Data Integrity Issues - DMS hot fixesFDA Data Integrity Issues - DMS hot fixes
FDA Data Integrity Issues - DMS hot fixes
 
Pharmaceutical Data integrity training
Pharmaceutical Data integrity trainingPharmaceutical Data integrity training
Pharmaceutical Data integrity training
 
Delta GMP Data Integrity Sept2016
Delta GMP Data Integrity Sept2016Delta GMP Data Integrity Sept2016
Delta GMP Data Integrity Sept2016
 
CTI Landing Page
CTI Landing PageCTI Landing Page
CTI Landing Page
 
Ensuring data integrity in pharmaceutical environment
Ensuring data integrity in pharmaceutical environmentEnsuring data integrity in pharmaceutical environment
Ensuring data integrity in pharmaceutical environment
 
Types of pharmacovigilance softwares
Types of pharmacovigilance softwaresTypes of pharmacovigilance softwares
Types of pharmacovigilance softwares
 
Reconciliation and Literature Review and Signal Detection_Katalyst HLS
Reconciliation and Literature Review and Signal Detection_Katalyst HLSReconciliation and Literature Review and Signal Detection_Katalyst HLS
Reconciliation and Literature Review and Signal Detection_Katalyst HLS
 
Finding the right medical device information in embase 11 2016
Finding the right medical device information in embase 11 2016Finding the right medical device information in embase 11 2016
Finding the right medical device information in embase 11 2016
 
Data integrity
Data integrityData integrity
Data integrity
 
Data integrity: TGA expectations
Data integrity: TGA expectationsData integrity: TGA expectations
Data integrity: TGA expectations
 

Similar to FDA MAUDE DB Text Search Insights

Data Management in Clinical Research
Data Management in Clinical ResearchData Management in Clinical Research
Data Management in Clinical Research
ijtsrd
 
Demystifying SPL for Medical Devices
Demystifying SPL for Medical DevicesDemystifying SPL for Medical Devices
Demystifying SPL for Medical Devices
dclsocialmedia
 
FDA Medical Device Guidance
FDA Medical Device GuidanceFDA Medical Device Guidance
FDA Medical Device Guidance
Market iT
 
Pfwd Level 02 Research 04 07 2010 (1)
Pfwd Level 02 Research 04 07 2010 (1)Pfwd Level 02 Research 04 07 2010 (1)
Pfwd Level 02 Research 04 07 2010 (1)
dlandsma
 
A Perspective Study of Warning Letters on Data Integrity Issued by FDA betwee...
A Perspective Study of Warning Letters on Data Integrity Issued by FDA betwee...A Perspective Study of Warning Letters on Data Integrity Issued by FDA betwee...
A Perspective Study of Warning Letters on Data Integrity Issued by FDA betwee...
ijtsrd
 
Practical Guide - www.devicematters.com
Practical Guide - www.devicematters.comPractical Guide - www.devicematters.com
Practical Guide - www.devicematters.com
PowerViz
 
Challenges and Opportunities Around Integration of Clinical Trials Data
Challenges and Opportunities Around Integration of Clinical Trials DataChallenges and Opportunities Around Integration of Clinical Trials Data
Challenges and Opportunities Around Integration of Clinical Trials Data
CitiusTech
 
The fda and byod mobile and fixed medical device cybersecurity[1]
The fda and byod mobile and fixed medical device cybersecurity[1]The fda and byod mobile and fixed medical device cybersecurity[1]
The fda and byod mobile and fixed medical device cybersecurity[1]
Pam Gilmore
 
The FDA and BYOD, Mobile and Fixed Medical Device Cybersecurity
The FDA and BYOD, Mobile and Fixed Medical Device CybersecurityThe FDA and BYOD, Mobile and Fixed Medical Device Cybersecurity
The FDA and BYOD, Mobile and Fixed Medical Device Cybersecurity
Valdez Ladd MBA, CISSP, CISA,
 
Modification after Initial Review and Transparency and Real-World Performance...
Modification after Initial Review and Transparency and Real-World Performance...Modification after Initial Review and Transparency and Real-World Performance...
Modification after Initial Review and Transparency and Real-World Performance...
EMMAIntl
 
Electronic Submissions Speech
Electronic Submissions SpeechElectronic Submissions Speech
Electronic Submissions Speech
MedTech Review, LLC
 
A Roadmap for SAS Programmers to Clinical Statistical Programming
A Roadmap for SAS Programmers to Clinical Statistical ProgrammingA Roadmap for SAS Programmers to Clinical Statistical Programming
A Roadmap for SAS Programmers to Clinical Statistical Programming
Mohammad Majharul Alam
 
Health informatics: delivering medical product information to the point of pa...
Health informatics: delivering medical product information to the point of pa...Health informatics: delivering medical product information to the point of pa...
Health informatics: delivering medical product information to the point of pa...
Myron Finseth, MSc
 
Late Binding: The New Standard For Data Warehousing
Late Binding: The New Standard For Data WarehousingLate Binding: The New Standard For Data Warehousing
Late Binding: The New Standard For Data Warehousing
Health Catalyst
 
FDA Regulations and Telehealth: Devices, Networks and Institutions
FDA Regulations and Telehealth: Devices, Networks and InstitutionsFDA Regulations and Telehealth: Devices, Networks and Institutions
FDA Regulations and Telehealth: Devices, Networks and Institutions
Mid-Atlantic Telehealth Resource Center
 
Disaster Recovery and Business Continuity for Your Clinical and Safety Systems
Disaster Recovery and Business Continuity for Your Clinical and Safety SystemsDisaster Recovery and Business Continuity for Your Clinical and Safety Systems
Disaster Recovery and Business Continuity for Your Clinical and Safety Systems
Perficient, Inc.
 
Mr Detail User Guide
Mr Detail User GuideMr Detail User Guide
Mr Detail User Guide
Jed_C_Morris
 
Best Practices: Cutting Through the Confusion & Avoiding the Pitfalls of Crea...
Best Practices: Cutting Through the Confusion & Avoiding the Pitfalls of Crea...Best Practices: Cutting Through the Confusion & Avoiding the Pitfalls of Crea...
Best Practices: Cutting Through the Confusion & Avoiding the Pitfalls of Crea...
dclsocialmedia
 
The Move to Mobile
The Move to MobileThe Move to Mobile
The Move to Mobile
Dale Cooke
 
IBM Insight 2014 session (4152 )- Accelerating Insights in Healthcare with “B...
IBM Insight 2014 session (4152 )- Accelerating Insights in Healthcare with “B...IBM Insight 2014 session (4152 )- Accelerating Insights in Healthcare with “B...
IBM Insight 2014 session (4152 )- Accelerating Insights in Healthcare with “B...
Alex Zeltov
 

Similar to FDA MAUDE DB Text Search Insights (20)

Data Management in Clinical Research
Data Management in Clinical ResearchData Management in Clinical Research
Data Management in Clinical Research
 
Demystifying SPL for Medical Devices
Demystifying SPL for Medical DevicesDemystifying SPL for Medical Devices
Demystifying SPL for Medical Devices
 
FDA Medical Device Guidance
FDA Medical Device GuidanceFDA Medical Device Guidance
FDA Medical Device Guidance
 
Pfwd Level 02 Research 04 07 2010 (1)
Pfwd Level 02 Research 04 07 2010 (1)Pfwd Level 02 Research 04 07 2010 (1)
Pfwd Level 02 Research 04 07 2010 (1)
 
A Perspective Study of Warning Letters on Data Integrity Issued by FDA betwee...
A Perspective Study of Warning Letters on Data Integrity Issued by FDA betwee...A Perspective Study of Warning Letters on Data Integrity Issued by FDA betwee...
A Perspective Study of Warning Letters on Data Integrity Issued by FDA betwee...
 
Practical Guide - www.devicematters.com
Practical Guide - www.devicematters.comPractical Guide - www.devicematters.com
Practical Guide - www.devicematters.com
 
Challenges and Opportunities Around Integration of Clinical Trials Data
Challenges and Opportunities Around Integration of Clinical Trials DataChallenges and Opportunities Around Integration of Clinical Trials Data
Challenges and Opportunities Around Integration of Clinical Trials Data
 
The fda and byod mobile and fixed medical device cybersecurity[1]
The fda and byod mobile and fixed medical device cybersecurity[1]The fda and byod mobile and fixed medical device cybersecurity[1]
The fda and byod mobile and fixed medical device cybersecurity[1]
 
The FDA and BYOD, Mobile and Fixed Medical Device Cybersecurity
The FDA and BYOD, Mobile and Fixed Medical Device CybersecurityThe FDA and BYOD, Mobile and Fixed Medical Device Cybersecurity
The FDA and BYOD, Mobile and Fixed Medical Device Cybersecurity
 
Modification after Initial Review and Transparency and Real-World Performance...
Modification after Initial Review and Transparency and Real-World Performance...Modification after Initial Review and Transparency and Real-World Performance...
Modification after Initial Review and Transparency and Real-World Performance...
 
Electronic Submissions Speech
Electronic Submissions SpeechElectronic Submissions Speech
Electronic Submissions Speech
 
A Roadmap for SAS Programmers to Clinical Statistical Programming
A Roadmap for SAS Programmers to Clinical Statistical ProgrammingA Roadmap for SAS Programmers to Clinical Statistical Programming
A Roadmap for SAS Programmers to Clinical Statistical Programming
 
Health informatics: delivering medical product information to the point of pa...
Health informatics: delivering medical product information to the point of pa...Health informatics: delivering medical product information to the point of pa...
Health informatics: delivering medical product information to the point of pa...
 
Late Binding: The New Standard For Data Warehousing
Late Binding: The New Standard For Data WarehousingLate Binding: The New Standard For Data Warehousing
Late Binding: The New Standard For Data Warehousing
 
FDA Regulations and Telehealth: Devices, Networks and Institutions
FDA Regulations and Telehealth: Devices, Networks and InstitutionsFDA Regulations and Telehealth: Devices, Networks and Institutions
FDA Regulations and Telehealth: Devices, Networks and Institutions
 
Disaster Recovery and Business Continuity for Your Clinical and Safety Systems
Disaster Recovery and Business Continuity for Your Clinical and Safety SystemsDisaster Recovery and Business Continuity for Your Clinical and Safety Systems
Disaster Recovery and Business Continuity for Your Clinical and Safety Systems
 
Mr Detail User Guide
Mr Detail User GuideMr Detail User Guide
Mr Detail User Guide
 
Best Practices: Cutting Through the Confusion & Avoiding the Pitfalls of Crea...
Best Practices: Cutting Through the Confusion & Avoiding the Pitfalls of Crea...Best Practices: Cutting Through the Confusion & Avoiding the Pitfalls of Crea...
Best Practices: Cutting Through the Confusion & Avoiding the Pitfalls of Crea...
 
The Move to Mobile
The Move to MobileThe Move to Mobile
The Move to Mobile
 
IBM Insight 2014 session (4152 )- Accelerating Insights in Healthcare with “B...
IBM Insight 2014 session (4152 )- Accelerating Insights in Healthcare with “B...IBM Insight 2014 session (4152 )- Accelerating Insights in Healthcare with “B...
IBM Insight 2014 session (4152 )- Accelerating Insights in Healthcare with “B...
 

Recently uploaded

NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
SwisschemDerma
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
Swastik Ayurveda
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Swastik Ayurveda
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
chandankumarsmartiso
 

Recently uploaded (20)

NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
 

FDA MAUDE DB Text Search Insights

  • 1. FDA MAUDE Data Insights Trevor Schmaeling
  • 2. MAUDE DataBase Introduction “MAUDE data represents reports of adverse events involving medical devices. The download data files consist of voluntary reports since June 1993, user facility reports since 1991, distributor reports since 1993, and manufacturer reports since August 1996. The searchable database data contains the last 10 year's data. MAUDE may not include reports made according to exemptions, variances, or alternative reporting requirements granted under 21 CFR 803.19.”(FDA)
  • 3. Project Background • Project started since I wanted to be able to find my own custom statistics on the MAUDE DB. A lot of statistics are difficult to come by, especially on a DB that receives little attention from the general public. • Information I provide is based on September 2021. • First step was to use the https://open.fda.gov/ API. However, at the time I used it, the data provided was not up to date (most recent month). • The next step I took was to download the data directly from the FDA.
  • 6. Check Data Structure, Then Add to DB
  • 7. Example of what a Table Looks Like 151K+ rows just for 1 month
  • 8. This is the Same Table Zoomed Out
  • 9. Search Through Text for “cobalt” To access the DB I created a basic search interface.
  • 10. Advanced Search is also an Option More fields such as “Date” can also be added
  • 11. Some Provided Results for “cobalt”
  • 12. Cobalt Device Problems Each “Device Code” corresponds to an actual name in text. I could have done a UNION sql search however the time it takes to receive results is not worth it. Will be updated by changing the code to text before displaying the graph.
  • 15. Search Through Text for “allergic reaction”
  • 16. Some Provided Results for “allergic reaction”
  • 20. Conclusions • Being able to search through MDR Summaries is a valuable tool for providing specific analysis. • Visually seeing the provided Device Problems, Patient Outcomes, and Event Types data of a keyword in an MDR summary can assist in root problem(s) diagnostics. • Although the MAUDE DB data is not 100% verified, the noise can be reduced through (eventual) further in-depth queries, as well as by looking at the trend.
  • 21. FDA Provided MAUDE Warnings • Please note that the MAUDE web search feature is limited to adverse event reports within the past 10 years. • MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices. • Confirming whether a device actually caused a specific event can be difficult based solely on information provided in a given report. Establishing a cause-and-effect relationship is especially difficult if circumstances surrounding the event have not been verified or if the device in question has not been directly evaluated. • MAUDE data does not represent all known safety information for a reported medical device and should be interpreted in the context of other available information when making device-related or treatment decisions. • Variations in trade, product, and company names affect search results. Searches only retrieve records that contain the search term(s) provided by the requester. • Submission of a medical device report and the FDA's release of that information is not necessarily an admission that a product, user facility, importer, distributor, manufacturer, or medical personnel caused or contributed to the event. • Certain types of report information are protected from public disclosure under the Freedom of Information Act (FOIA). If a report contains trade secret or confidential business information, that text is replaced by "(b)(4)". If a report contains personnel or medical files information, that text is replaced by "(b)(6)". The designations "(b)(4)" and "(b)(6)" refer to the exemptions in the FOIA. For example, "(b)(4)" may be found in place of the product's composition and "(b)(6)" may be found in place of a patient's age. • MAUDE is updated monthly and the search page reflects the date of the most recent update. The FDA seeks to include all reports received prior to the update but the inclusion of some reports may be delayed.